Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | SLMO2 |
| Upstream (Parents) |
|---|
| (<<) GNG12 → SLMO2 |
| (<<) GRB10 → SLMO2 |
| (<<) KLF6 → SLMO2 |
| (<<) MAP3K6 → SLMO2 |
| (<<) MMP2 → SLMO2 |
| (<<) NCOA3 → SLMO2 |
| (<<) PLA2R1 → SLMO2 |
| (<<) PPP1R3D → SLMO2 |
| (<<) RAB22A → SLMO2 |
| (<<) YRDC → SLMO2 |
| Downstream (Children) |
|---|
| SLMO2 → BDH1 (>>) |
| SLMO2 → DNM1L (>>) |
| SLMO2 → EIF4E (>>) |
| SLMO2 → GSTM3 (>>) |
| SLMO2 → HSPA14 (>>) |
| SLMO2 → IGFBP4 (>>) |
| SLMO2 → ITCH (>>) |
| SLMO2 → LOC92249 (>>) |
| SLMO2 → NFIA (>>) |
| SLMO2 → PNO1 (>>) |
| SLMO2 → RNF5 (>>) |
| SLMO2 → TCEB1 (>>) |
| SLMO2 → TCF7L1 (>>) |
